Representative before the EPO

Company dna sagittarius ip
no operation time available
1 office
active in Legal Services

We have observed 69 EP applications Andrew John Teuten has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11729448

P38 MAP KINASE INHIBITORS

IPC classification:
A61P 11/00, C07D 401/12, C07D 401/14, C07D 405/14, C07D 409/14, A61K 31/4155
Applicant:
Respivert Ltd
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP11705985

PROTEIN FORMULATIONS

IPC classification:
A61K 9/00, A61K 39/395, A61K 47/12
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP11708813

IMMOBILISED BIOLOGICAL ENTITIES

IPC classification:
A61L 33/00
Agent:
Andrew John Teuten, Sagittarius IP
Status:
The patent has been granted
EP11751030

SYSTEM AND METHOD FOR COMPRESSED BED GRINDING IN A STIRRED MEDIA MILL

IPC classification:
B02C 17/02, B07B 13/00
Agent:
Andrew John Teuten, Sagittarius IP
Status:
APPLICATION WITHDRAWN
EP13166988

Methods and compositions for administration of iron

IPC classification:
A61P 7/06, A61K 31/715
Agent:
Andrew John Teuten, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11183688

1-Pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl)ureas as p38 MAP kinase inhibitors

IPC classification:
C07D 403/12, A61K 31/4155, A61K 31/506
Agent:
Andrew John Teuten, Sagittarius IP
Status:
APPLICATION REFUSED
EP12704527

COMBINATION THERAPY FOR CANCER

IPC classification:
A61P 35/00, A61K 38/45, A61K 48/00
Agent:
Andrew John Teuten, Sagittarius IP
Status:
The patent has been granted
EP12864756

BAP1 MUTATIONAL ANALYSIS IN DETERMINING SUSCEPTIBILITY TO, PROGNOSIS OF, AND TREATMENT OF MELANOCYTIC NEOPLASIA

IPC classification:
G01N 33/48, G01N 33/53
Applicant:
Graz University of Medicine (Medizinische Universit├Ąt Graz)
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP11191986

Novel pyrrole compounds

IPC classification:
A61P 31/04, C07C 211/48, C07D 207/36, C07D 401/04, C07D 401/12, C07D 403/04, C07D 407/04, C07D 413/04, C07D 417/04, A61K 31/402, A61K 31/4245, A61K 31/427, A61K 31/4439
Agent:
Andrew John Teuten, Sagittarius IP
Status:
APPLICATION REFUSED
EP12708138

IMPROVEMENTS TO IMMOBILISED BIOLOGICAL ENTITIES

IPC classification:
A61K 47/48, A61L 27/34, A61L 31/10, A61L 33/00
Applicant:
W.L. Gore & Associates Inc
Agent:
Andrew John Teuten, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP12723442

CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHODS FOR THE PREPARATION AND USES THEREOF

IPC classification:
A61P 37/00, C12N 5/0783, A61K 35/14, A61K 39/00
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP12741268

NK-1 RECEPTOR ANTAGONISTS FOR TREATING CORNEAL NEOVASCULARISATION

IPC classification:
A61P 27/02, A61K 31/445, A61K 31/5377, A61K 31/675, A61K 45/06
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP12772383

1-PYRAZOLYL-3- (4- ( (2 -ANILINOPYRIMIDIN- 4 - YL) OXY) NAPTHTHALEN- 1 - YL) UREAS AS P38 MAP KINASE INHIBITORS

IPC classification:
C07D 403/12, C07D 491/10, A61K 31/4155, A61K 31/506
Applicant:
Respivert Ltd
Agent:
Andrew John Teuten, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12772382

L-PYRAZOLYL-3- (4- ( (2 -ANILINOPYRIMIDIN- 4 - YL) OXY) NAPTHTHALEN- 1 - YL) UREAS AS P3I MAP KINASE INHIBITORS

IPC classification:
C07D 403/12, A61K 31/4155, A61K 31/506
Applicant:
Respivert Ltd
Agent:
Andrew John Teuten, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12839144

DIMERIC BACTERIOPHAGE LYSINS

IPC classification:
C12N 7/00
Applicant:
The Rockefeller University
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP12884742

NOVEL COMPOUND FOR IMAGING TAU PROTEIN ACCUMULATED IN THE BRAIN

IPC classification:
A61P 25/28, C07D 277/64, C07D 401/06, C07D 405/06, C07D 417/06, C07D 417/14, A61K 49/00, A61K 51/00
Agent:
Andrew John Teuten, Sagittarius IP
Status:
PATENT GRANTED
EP11706318

STABLE COMPOSITIONS OF FACTOR IX

IPC classification:
C12N 9/64, A61K 38/36
Agent:
Andrew John Teuten, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13189447

Immobilized biologically active entities having a high degree of biological activity

IPC classification:
A61K 31/727, A61K 38/17, A61L 2/00, A61L 27/20, A61L 27/34, A61L 27/54, A61L 31/10, A61L 31/12, A61L 33/00, A61L 33/06, A61L 33/08
Applicant:
W.L. Gore & Associates Inc
Agent:
Andrew John Teuten, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP14175887

Novel compound useful for the treatment of degenerative and inflammatory diseases

IPC classification:
A61P 29/00, A61P 35/00, A61P 37/00, C07D 471/04, A61K 31/437
Applicant:
Galapagos NV
Agent:
Andrew John Teuten, Sagittarius IP
Status:
PATENT GRANTED
EP12774625

STREPTOCOCCUS BACTERIOPHAGE LYSINS FOR TREATMENT OF GRAM POSITIVE BACTERIA IN COMPANION ANIMALS AND LIVESTOCK

IPC classification:
A61K 38/47
Applicant:
Universiteit Utrecht Holding BV
Applicant:
The Rockefeller University
Agent:
Andrew John Teuten, Sagittarius IP
Status:
APPLICATION WITHDRAWN
EP12869333

DETECTION OF SPECIFIC ANTIGENS IN A POPULATION OF ANTIGENS

IPC classification:
G01N 33/53, G01N 33/566, G01N 33/567
Agent:
Andrew John Teuten, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP11803026

NON-INVASIVE MEASUREMENT OF BLOOD OXYGEN SATURATION

IPC classification:
A61B 5/00, A61B 5/026, A61B 5/145, A61B 5/1455
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP12762365

OPHTHALMIC FORMULATIONS

IPC classification:
A61P 31/00, A61P 31/04, A61P 31/10, A61K 9/00, A61K 9/08, A61K 9/12, A61K 31/79, A61K 33/18, A61K 47/38
Agent:
Andrew John Teuten, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13757471

METHODS FOR MODULATION OF PHOSPHORUS AND FGF23

IPC classification:
A01N 59/16, A61K 38/21, A61K 39/00, A61K 51/00
Agent:
Andrew John Teuten, Sagittarius IP
Status:
APPLICATION WITHDRAWN
EP13758033

TGF- 1 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF

IPC classification:
C07K 16/00, A61K 39/395
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP13711104

NOVEL PHARMACEUTICAL FORMULATIONS

IPC classification:
C07D 487/04, A61K 9/00, A61K 47/12, A61K 47/26
Applicant:
Respivert Ltd
Agent:
Andrew John Teuten, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13711105

CRYSTALLINE PI3 KINASE INHIBITORS

IPC classification:
C07D 487/04
Applicant:
Respivert Ltd
Agent:
Andrew John Teuten, Sagittarius IP
Status:
PATENT GRANTED
EP13778780

HUMAN ANTIBODIES AND SPECIFIC BINDING SEQUENCES THEREOF FOR USE IN STROKE AND ISCHEMIA OR ISCHEMIC CONDITIONS

IPC classification:
A61K 39/395
Applicant:
Mayo Foundation for Medical Education and Research
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Andrew John Teuten, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13787555

BIOFILM PREVENTION, DISRUPTION AND TREATMENT WITH BACTERIOPHAGE LYSIN

IPC classification:
C12N 9/52, A61K 38/00, A61K 39/085
Agent:
Andrew John Teuten, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13800583

POWER DOOR OPENER

IPC classification:
B66F 19/00
Agent:
Andrew John Teuten, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13787128

BACTERIOPHAGE LYSIN AND ANTIBIOTIC COMBINATIONS AGAINST GRAM POSITIVE BACTERIA

IPC classification:
C12N 9/52, A61K 39/085
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP13797721

TISSUE REPAIR DEVICES AND SCAFFOLDS

IPC classification:
A61F 2/02, A61F 2/28, A61L 27/54, A61L 27/56
Applicant:
New York University
Agent:
Andrew John Teuten, Sagittarius IP
Status:
APPLICATION WITHDRAWN
EP13766525

CELL LINES

IPC classification:
C12N 15/67, C12P 21/02
Applicant:
MedImmune Limited
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP13766526

AMINO ACID DERIVATIVES

IPC classification:
C07C 233/49, C07C 233/56, C07C 247/04, C07C 271/12, C07C 271/20, C07C 271/22, C12N 15/67, C12P 21/02
Applicant:
MedImmune Limited
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP14787478

TREATMENT OF ALZHEIMER'S AND COGNITIVE IMPAIRMENT WITH ANDROGRAPHOLIDES

IPC classification:
A61P 25/28, A61K 31/365, A61K 36/19
Agent:
Andrew John Teuten, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP12858356

DECELLULARIZED SMALL PARTICLE TISSUE

IPC classification:
A61K 38/39
Agent:
Andrew John Teuten, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP11787742

QUINAZOLIN-4(3H)-ONE DERIVATIVES USED AS PI3 KINASE INHIBITORS

IPC classification:
A61P 11/00, A61P 11/06, A61P 17/00, A61P 19/02, A61P 35/00, C07D 487/04, A61K 31/519
Applicant:
Respivert Ltd
Agent:
Andrew John Teuten, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14717612

POROUS COMPOSITES WITH PACLITAXEL CRYSTALS

IPC classification:
A61K 31/337, A61L 27/34, A61L 29/14
Applicant:
W.L. Gore & Associates Inc
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP14714307

STABLE AQUEOUS FORMULATIONS OF ADENOVIRUS VECTORS

IPC classification:
C12N 15/86, A61K 9/00, A61K 47/36, A61K 48/00
Agent:
Andrew John Teuten, Sagittarius IP
Status:
The patent has been granted
EP14721092

COATING FOR A SURFACE

IPC classification:
A61L 27/34, A61L 29/08, A61L 31/10
Applicant:
W.L. Gore & Associates Inc
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14712334

2-((4-AMINO-3-(3-FLUORO-5-HYDROXYPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-1 -YL)METHYL)-3-(2-(TRIFLUOROMET HYL)BENZYL)QUINAZOLIN-4(3H)-ONE DERIVATIVES AND THEIR USE AS PHOSPHOINOSITIDE 3-KINASE INHIBITORS

IPC classification:
A61P 11/00, A61P 17/00, A61P 19/00, A61P 31/12, A61P 35/00, C07D 487/04, A61K 31/519
Applicant:
Respivert Ltd
Agent:
Andrew John Teuten, Sagittarius IP
Status:
The patent has been granted
EP15188438

AMIDO COMPOUNDS AS RORYT MODULATORS AND USES THEREOF

IPC classification:
C07C 235/34, C07C 235/36, C07D 317/54, C07D 317/60, C07D 401/10, C07D 403/14, C07D 405/06, A61K 31/12, A61K 31/33, A61K 31/4453, A61K 31/4525, A61K 31/535
Applicant:
New York University
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP11753726

AMIDO COMPOUNDS AS RORyt MODULATORS AND USES THEREOF

IPC classification:
A61P 29/00, A61P 37/00, C07C 235/34, C07C 235/36, C07D 211/16, C07D 307/52, C07D 317/54, C07D 317/60, C07D 403/14, C07D 405/06, A61K 31/4025, A61K 31/404, A61K 31/4453, A61K 31/4525, A61K 31/453, A61K 31/495, A61K 31/496, A61K 31/535, A61K 31/5375
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Applicant:
New York University
Agent:
Andrew John Teuten, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11810417

COMBINATION THERAPY WITH MDM2 AND EFGR INHIBITORS

IPC classification:
A61P 35/00, A61K 31/4709, A61K 31/517, A61K 45/06
Agent:
Andrew John Teuten, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11713510

PYRAZOLE P38 MAP KINASE INHIBITORS

IPC classification:
A61P 11/06, A61P 17/00, A61P 17/06, A61P 29/00, A61P 35/00, C07D 401/12, C07D 401/14, C07D 403/12, A61K 31/4439, A61K 31/506
Agent:
Andrew John Teuten, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11728920

UREIDO-PYRAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF RHINOVIRUS INFECTIONS

IPC classification:
A61P 11/00, A61P 11/06, A61P 31/00, A61P 31/16, C07D 401/12, C07D 401/14, C07D 403/12, C07D 405/14, C07D 413/14, A61K 31/415, A61K 31/4439, A61K 31/496, A61K 31/5377
Applicant:
Respivert Ltd
Agent:
Andrew John Teuten, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11779842

NOVEL COMPOSITION COMPRISING GLUCAGON

IPC classification:
A61K 38/26
Agent:
Andrew John Teuten, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14851038

AMINO, AMIDO, AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF

IPC classification:
A61P 25/28
Applicant:
New York University
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP11795278

NEW CATHEPSIN S PROTEASE INHIBITORS, USEFUL IN THE TREATMENT OF E.G. AUTOIMMUNE DISORDERS, ALLERGY AND CHRONIC PAIN CONDITIONS

IPC classification:
A61P 11/00, A61P 37/00, C07C 237/14, C07D 233/58, A61K 31/16
Agent:
Andrew John Teuten, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11738789

STABILIZED AQUEOUS ANTIBODY COMPOSITIONS

IPC classification:
C07K 16/00, C07K 16/22, C07K 16/28, C07K 16/32, A61K 39/00, A61K 39/395, A61K 47/34
Agent:
Andrew John Teuten, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12859754

COMBINATION THERAPY WITH INTERFERON BETA AND ANDROGRAPHOLIDES FOR MULTIPLE SCLEROSIS

IPC classification:
A61P 25/00, A61K 31/341, A61K 38/21
Agent:
Andrew John Teuten, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14805880

IONIC AQUEOUS COMPOSITIONS

IPC classification:
A61P 11/00, A61P 31/00, A61P 31/16, A61K 35/74, A61K 36/03, A61K 36/04, A61K 36/53
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP16172826

METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON

IPC classification:
A61P 7/06, A61K 31/715
Agent:
Gille Habral
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14862298

EPHEDRA ALATA EXTRACTS AND METHODS OF USE THEREOF

IPC classification:
A61K 36/17
Agent:
Andrew John Teuten, Sagittarius IP
Status:
APPLICATION WITHDRAWN
EP11704308

SANGLIFEHRIN BASED COMPOUNDS

IPC classification:
A61K 31/5025
Agent:
Marianne Johansen, Chas. Hude AS
Agent:
Andrew John Teuten, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11708188

NUTRACEUTICAL CHOCOLATE OR COMPOUND CHOCOLATE PRODUCT

IPC classification:
A61P 27/02, A61P 39/06, A23G 1/42, A23G 1/54, A61K 9/00
Agent:
Andrew John Teuten, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15740526

WRAP AROUND BED FRAME

IPC classification:
A47C 19/02
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15746159

PROGRANULIN (PGRN) AND ITS DERIVATIVES FOR DIAGNOSIS AND TREATMENT OF LYSOSOMAL STORAGE DISEASES

IPC classification:
A61P 3/00
Applicant:
New York University
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15705797

AROMATIC HETEROCYCLIC COMPOUNDS AS ANTIINFLAMMATORY COMPOUNDS

IPC classification:
A61P 29/00, A61P 37/00, C07D 401/14, A61K 31/497
Applicant:
Respivert Ltd
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15706511

PYRAZOLYL-UREAS AS KINASE INHIBITORS

IPC classification:
A61P 11/00, A61P 29/00, A61P 31/00, C07D 401/14, C07D 409/14, A61K 31/506
Applicant:
Respivert Ltd
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15796715

THREE DIMENSIONAL CONNECTION SYSTEM FOR BED FRAME

IPC classification:
A47C 19/02
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15845303

SEEDING AN ADHERENT CELL BIOREACTOR WITH NON-ADHERENT CELLS INCREASES SEEDING DENSITY LIMIT AND REDUCES REQUIRED EXPANSION TIME

IPC classification:
C12N 5/00
Agent:
Andrew John Teuten, Sagittarius IP
Status:
Request for examination was made
EP15843649

NOVEL IMIDAZOPYRIDAZINE COMPOUNDS AND THEIR USE

IPC classification:
A61P 11/00, A61P 19/02, A61P 29/00, A61P 35/00, A61P 37/00, C07D 487/04, C07D 519/00, A61K 31/5025, A61K 31/505, A61K 31/519, A61K 31/52
Agent:
Andrew John Teuten, Sagittarius IP
Status:
Request for examination was made
EP15784440

NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVE

IPC classification:
A61P 31/14, C07D 495/04, A61K 31/55
Agent:
Andrew John Teuten, Sagittarius IP
Status:
Request for examination was made
EP15782045

NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVES

IPC classification:
A61P 31/14, C07D 495/04, A61K 31/55
Agent:
Andrew John Teuten, Sagittarius IP
Status:
Request for examination was made
EP15808770

ANTIMYCOTIC COMPOUND

IPC classification:
A61P 31/10, C07D 405/06
Agent:
Andrew John Teuten, Sagittarius IP
Status:
Request for examination was made
EP15817507

ANTIMYCOTIC COMPOUND

IPC classification:
A61P 31/10, C07D 405/06
Agent:
Andrew John Teuten, Sagittarius IP
Status:
Request for examination was made
EP15818022

4,5-DIHYDRO-6H-THIENO[3,2-D]BENZAZEPINE DERIVATIVES AND THEIR USE TO TREAT RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTIONS

IPC classification:
A61P 11/00, C07D 495/04, A61K 31/55
Agent:
Andrew John Teuten, Sagittarius IP
Status:
Request for examination was made
EP17181258

STREPTOCOCCUS BACTERIOPHAGE LYSINS FOR DETECTION AND TREATMENT OF GRAM POSITIVE BACTERIA

IPC classification:
A61P 31/04, C12N 9/36, A61K 38/16, A61K 38/47, A61K 38/50, A61K 45/06
Applicant:
The Rockefeller University
Agent:
Andrew John Teuten, Sagittarius IP
Status:
The application has been published

Please Sign in to use this feature